• Users Online: 72099
  • Home
  • Print this page
  • Email this page
This article has been cited by
1Branch Retinal Vein Occlusion: Treatment Modalities: An Update of the Literature
Irini P. Chatziralli,Adil Jaulim,Vasileios G. Peponis,Panagiotis G. Mitropoulos,Marilita M. Moschos
Seminars in Ophthalmology.2014;29(2)85
[DOI]
2Changes in aqueous cytokines after intravitreal triamcinolone versus bevacizumab for macular oedema in branch retinal vein occlusion
Hee Jin Sohn,Dae Heon Han,Dae Yeong Lee,Dong Heun Nam
Acta Ophthalmologica.2014;92(3)85
[DOI]
3Short-term efficacy of intravitreal triamcinolone acetonide for macular edema secondary to retinal vein occlusion that is refractory to intravitreal bevacizumab
SeulGi Yoo,JaeHui Kim,TaeGon Lee,ChulGu Kim,JongWoo Kim
Indian Journal of Ophthalmology.2015;63(1)25
[DOI]
4Efficacy of Intravitreal Triamcinolone Acetonide in the Treatment of Macular Oedema in Retinal Vein Occlusion Refractory to Anti-VEGF Therapy - A Prospective Interventional Study from a Tertiary Care Centre in Eastern India
Pradeep Kumar Panigrahi,Suprava Das,Suchismita Mishra
Journal of Evidence Based Medicine and Healthcare.2021;8(24)2083
[DOI]
5Behandlung der Patienten mit einem Venenastverschluss in Abhängigkeit von der Verschlussdauer
M. Rehak,E. Spies,M. Scholz,P. Wiedemann
Der Ophthalmologe.2013;110(10)966
[DOI]

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal